Question 1

Does JPMorgan Chase own PCVX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 1,227,346 shares of PCVX (Vaxcyte), worth $71.2M.

Question 2

How many shares of PCVX does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 1,227,346 shares of PCVX (Vaxcyte).

Question 3

What is JPMorgan Chase's PCVX position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's PCVX position is worth $71.2M.

Question 4

Is JPMorgan Chase buying or selling PCVX?

Accepted Answer

In Q2 2026, JPMorgan Chase increased its PCVX position by 219,032 shares (+21.7%).

Question 5

When did JPMorgan Chase first buy PCVX?

Accepted Answer

JPMorgan Chase already held PCVX in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.2M	+21.7%	$71.2M	0.0%	$58.13	36
2026-Q1	Decreased	1M	-7.1%	$55.4M	0.0%	$59.82	0
2025-Q4	Decreased	1.1M	-30.6%	$50.1M	0.0%	$46.14	0
2025-Q3	Increased	1.6M	+30.6%	$56.4M	0.0%	$36.02	37
2025-Q2	Decreased	1.2M	-36.9%	$39M	0.0%	$32.58	0
2025-Q1	Increased	1.9M	+9.5%	$71.8M	0.0%	$69.46	32
2024-Q4	Increased	1.7M	+21.6%	$142.1M	0.0%	$81.86	36
2024-Q3	First report	1.4M	-	$163.2M	0.0%	$114.27	0

PCVX8 quarters

PCVX
8 quarters